Fidelity & Guaranty Life sells $160,566 of Crescent Capital BDC stock By Investing.com

Fidelity & Guaranty Life Insurance Co., a 10% owner and director of Crescent Capital BDC, Inc. (NASDAQ:CCAP), sold shares totaling $160,566 over two days in early September 2026. The transactions involved the sale of 15,482 shares of common stock, with prices ranging from $10.3395 to $10.3863 per share. On September 3, 2026, Fidelity & Guaranty Life Insurance Co. disposed of 5,011 shares at a volume-weighted average price of $10.3395 per share. These shares were sold in multiple transactions at prices ranging from $10.31 to $10.38 per share. The following day, September 4, 2026, an additional 10,471 shares were sold at a volume-weighted average price of $10.3863 per share, with individual transaction prices ranging from $10.36 to $10.43 per share. Following these transactions, Fidelity & Guaranty Life Insurance Co. beneficially owns 3,945,797 shares of Crescent Capital BDC common stock. These shares are held indirectly by Fidelity & Guaranty Life Insurance Company of New York, a wholly owned subsidiary of the reporting person. In other recent news, Crescent Capital BDC Inc. reported its second-quarter 2026 financial results, revealing a net investment income of $0.36 per share. This figure fell slightly short of Wall Street's estimate of $0.3667 per share. Additionally, the company announced that its net investment income was sufficient to cover its $0.34 base dividend and to help fund a previously announced special payout. However, revenue also came in below forecasts. In another development, Keefe, Bruyette & Woods downgraded Crescent BDC's stock rating from Outperform to Market Perform. The firm cited concerns over a 2.5% decline in net asset value and deteriorating credit quality over the past two years as reasons for the downgrade. Keefe, Bruyette & Woods also adjusted their price target for the company from $13.00 to $12.00. These recent developments highlight the challenges Crescent Capital BDC is currently facing. This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.